Showing results (161-170 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|December 20, 2003
Immunobiology of HER-2/neu oncoprotein and its potential application in cancer immunotherapyConstantin N Baxevanis, Panagiota A Sotiropoulou, Nectaria N Sotiriadou, et al.Cancer Immunology, Immunotherapy : CII|November 25, 2003
Impact of the tumor microenvironment on host infiltrating cells and the efficacy of flt3-ligand combination immunotherapy evaluated in a treatment model of mouse prostate cancerRichard P Ciavarra, Roy R Brown, Daniel A Holterman, et al.Cancer Immunology, Immunotherapy : CII|November 25, 2003
Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neckDavid R Colnot, Jan C Roos, Remco de Bree, et al.Cancer Immunology, Immunotherapy : CII|November 19, 2003
In vivo priming of natural killer T cells by dendritic cells pulsed with hepatoma-derived acid-eluted substancesRitsuko Ishii, Masumi Shimizu, Yohko Nakagawa, et al.Cancer Immunology, Immunotherapy : CII|December 3, 2003
Heated tumour cells of autologous and allogeneic origin elicit anti-tumour immunityStephen M Todryk, Jonathan Eaton, Lindsay Birchall, et al.Cancer Immunology, Immunotherapy : CII|December 3, 2003
Clinical applications of dendritic cell vaccination in the treatment of cancerLee D Cranmer, Katrina T Trevor, Evan M HershCancer Immunology, Immunotherapy : CII|December 3, 2003
A highly effective and stable bispecific diabody for cancer immunotherapy: cure of xenografted tumors by bispecific diabody and T-LAK cellsHiroki Hayashi, Ryutaro Asano, Kouhei Tsumoto, et al.Cancer Immunology, Immunotherapy : CII|January 24, 2004
A primer on cancer immunology and immunotherapyMichael T Lotze, Michael PapamichailCancer Immunology, Immunotherapy : CII|February 5, 2004
Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSABenoît Barrou, Gérard Benoît, Mahmoud Ouldkaci, et al.Cancer Immunology, Immunotherapy : CII|January 17, 2004
Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloningDirk Jäger, Christian Taverna, Alfred Zippelius, et al.Pageof 650